According to Dechra Pharmaceuticals's latest financial reports the company has $0.10 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-06-30 | $0.14 B | -10.51% |
2021-06-30 | $0.16 B | -41.45% |
2020-06-30 | $0.27 B | 174.62% |
2019-06-30 | $0.10 B | -3.16% |
2018-06-30 | $0.10 B | 32.2% |
2017-06-30 | $79.62 M | 51.07% |
2016-06-30 | $52.7 M | -27.08% |
2015-06-30 | $72.28 M | 58.5% |
2014-06-30 | $45.6 M | -8.53% |
2013-06-30 | $49.85 M | -1.98% |
2012-06-30 | $50.86 M | 3.75% |
2011-06-30 | $49.02 M | 4.14% |
2010-06-30 | $47.07 M | 6.61% |
2009-06-30 | $44.15 M | -0.28% |
2008-06-30 | $44.28 M | 27.43% |
2007-06-30 | $34.75 M | -4.78% |
2006-06-30 | $36.49 M | 46.41% |
2005-06-30 | $24.92 M | |
2004-06-30 | $N/A | |
2002-06-30 | $N/A | -100% |
2001-06-30 | $5.06 M |